Biotech News

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Octobre 2026

Sanofi (SNY)SanofiCompany update

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers

Related news

Sanofi

Global Biopharmaceutical Company Sanofi is a global biopharmaceutical company with major businesses in specialty medicines and vaccines. Its research and commercial portfolio is concentrated in immunology, rare diseases, hematology, neurology, oncology, and infectious-disease prevention. Dupixent-Led Immunology Franchise Dupixent,...

Recent company news

Stock data

Close
46.06 USD
Market cap
102.45B USD
Exchange
NASDAQ
Sector
Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines
Location
United States